Alix Rouault, PhD profile page

Dr. Alix Rouault is senior scientist and lead biologist at Superluminal Medicines where he oversees two programs. Rouault earned his PhD in molecular biology, physiology, and biophysics from the University of Iowa, specializing in GPCR biased signaling induced by accessory proteins. His research in this field has been featured in several leading journals and a book chapter. Rouault further refined his drug discovery skills and gained in vivo experience during his postdoctoral fellowship at the University of Michigan’s Life Sciences Institute. In 2024, he began consulting for Superluminal Medicines, a Boston-based biotechnology company dedicated to efficient drug development through integrated in silico and in vitro approaches. Rouault also serves as an executive member of the Industry Science Committee at the American Society for Pharmacology and Experimental Therapeutics.